Manuka Honey Irrigation After Sinus Surgery
Launched by ST. PAUL'S HOSPITAL, CANADA · May 6, 2011
Trial Information
Current as of May 23, 2025
Completed
Keywords
ClinConnect Summary
All patients in this study will undergo endoscopic sinus surgery. This is the mainstay of treatment for patients with refractory sinus disease.
All patients that undergo endoscopic sinus surgery must routinely complete nasal irrigations to maintain the patency of the sinuses and to encourage healing. The current standard of treatment is saline irrigations. Manuka honey has already shown promise in the field of wound healing. The Manuka Honey will be used as the treatment arm in this study and will be compared to the current standard of care, the saline irrigations.
Once the subjects have ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ability to provide informed consent.
- • Adult (over 19 years of age) patients undergoing sinus surgery for chronic rhinosinusitis (CRS) or allergic fungal sinusitis (AFS).
- Exclusion Criteria:
- • Co-morbidities, eg. Hypertension, Cardiac Disease, Coagulopathy, CF, Sampter's triad, Diabetes, liver failure
- • Medication, eg. Anticoagulants, statins, anti-hypertensives
- • Allergies to honey, bee stings
About St. Paul's Hospital, Canada
St. Paul's Hospital, located in Vancouver, Canada, is a leading healthcare institution renowned for its commitment to advancing medical research and improving patient care. As a prominent clinical trial sponsor, the hospital fosters innovative studies across various medical fields, focusing on translating research findings into effective treatments. With a multidisciplinary team of experienced clinicians and researchers, St. Paul's Hospital emphasizes collaboration and ethical standards, ensuring that trials are conducted with the utmost integrity and patient safety. The institution is dedicated to enhancing health outcomes through rigorous scientific inquiry and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Amin R Javer, MD, FRCSC
Principal Investigator
St. Paul's Hospital, Canada
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials